Response to: Genetic risk scores may compound rather than solve the issue of prostate cancer overdiagnosis (BJC-LT3342090)

Affiliations

• ¹ Exeter Centre of Excellence for Diabetes Research (EXCEED), University of Exeter Medical School, St Luke's Campus, University of Exeter, Heavitree Road, Devon, Exeter, EX1 2LU, UK.
• ² DISCOVERY Group, University of Exeter Medical School, St Luke's Campus, University of Exeter, Heavitree Road, Devon, Exeter, EX1 2LU, UK.
• ³ Institute of Biomedical and Clinical Science, University of Exeter Medical School, St Luke's Campus, University of Exeter, Heavitree Road, Devon, Exeter, EX1 2LU, UK.
• ⁴ Genetics of Complex Traits, University of Exeter Medical School, University of Exeter, Exeter, EX2 5DW, UK.
• ⁵ Institute for Molecular Medicine (FIMM), University of Helsinki, Helsinki, Finland.
• ⁶ University of Exeter Medical School, St Luke's Campus, University of Exeter, Heavitree Road, Devon, Exeter, EX1 2LU, UK.
• ⁷ UCL Cancer Institute, Huntley St, EX1 2LU, London, UK.
• ⁸ DISCOVERY Group, University of Exeter Medical School, St Luke's Campus, University of Exeter, Heavitree Road, Devon, Exeter, EX1 2LU, UK. s.e.r.bailey@exeter.ac.uk.